Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

Nuwellis Strengthens Product Development Organization with Appointment of Dale Brady as Principal R&D Engineer

$NUWEPress releaseAug 6, 2026, 8:30 AM ETRead the release

Nuwellis appointed Dale Brady as Principal R&D Engineer to strengthen its product development organization and advance its pipeline programs. Brady brings over 25 years of experience in medical device R&D, operations, and commercialization, having previously held leadership roles at Peytant Solutions, Endogenex, and Osprey Medical.

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.